Boehringer Ingelheim, a German family-owned research-driven biopharmaceutical company and global leader in animal health, has announced the launch of NexGard SPECTRA® chewable tablets in India following its approval by the Central Drugs Standard Control Organisation. After the launch of NexGard X and L in 2020 and NexGard S and M (afoxolaner) in 2023, this represents an expansion of the NexGard product line for dogs aged at least two months and weighing 2 kg or more....